DE60032161D1 - P-glycoproteine und ihre verwendungen - Google Patents
P-glycoproteine und ihre verwendungenInfo
- Publication number
- DE60032161D1 DE60032161D1 DE60032161T DE60032161T DE60032161D1 DE 60032161 D1 DE60032161 D1 DE 60032161D1 DE 60032161 T DE60032161 T DE 60032161T DE 60032161 T DE60032161 T DE 60032161T DE 60032161 D1 DE60032161 D1 DE 60032161D1
- Authority
- DE
- Germany
- Prior art keywords
- dog
- pgp
- glycoproteins
- inhibitors
- glycoprotein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108010091105 Subfamily B ATP Binding Cassette Transporter Proteins 0.000 title abstract 3
- 102000018075 Subfamily B ATP Binding Cassette Transporter Human genes 0.000 title abstract 3
- 102100033350 ATP-dependent translocase ABCB1 Human genes 0.000 abstract 2
- 108010047230 Member 1 Subfamily B ATP Binding Cassette Transporter Proteins 0.000 abstract 2
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 229940049937 Pgp inhibitor Drugs 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Cell Biology (AREA)
- Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15651099P | 1999-09-28 | 1999-09-28 | |
| PCT/US2000/026767 WO2001023540A2 (en) | 1999-09-28 | 2000-09-28 | P-glycoproteins and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60032161D1 true DE60032161D1 (de) | 2007-01-11 |
Family
ID=22559872
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60032161T Expired - Lifetime DE60032161D1 (de) | 1999-09-28 | 2000-09-28 | P-glycoproteine und ihre verwendungen |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1220911B1 (enExample) |
| JP (2) | JP2003510071A (enExample) |
| AT (1) | ATE346924T1 (enExample) |
| AU (1) | AU785363B2 (enExample) |
| CA (1) | CA2384981A1 (enExample) |
| DE (1) | DE60032161D1 (enExample) |
| WO (1) | WO2001023540A2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2411101C (en) * | 2000-06-05 | 2018-01-16 | Brigham And Women's Hospital, Inc. | A gene encoding a multidrug resistance human p-glycoprotein homologue on chromosome 7p15-21 and uses thereof |
| US6855812B2 (en) * | 2001-03-19 | 2005-02-15 | Becton, Dickinson And Company | P-glycoproteins and uses thereof |
| ES2796111T3 (es) | 2008-11-14 | 2020-11-25 | Brigham & Womens Hospital Inc | Métodos terapéuticos relacionados con células madre cancerosas |
| US11542328B2 (en) | 2008-11-14 | 2023-01-03 | The Brigham And Women's Hospital, Inc. | Therapeutic and diagnostic methods relating to cancer stem cells |
| KR20210005118A (ko) | 2018-04-25 | 2021-01-13 | 칠드런'즈 메디컬 센터 코포레이션 | Abcb5 리간드 및 기질 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993024613A1 (en) * | 1992-05-22 | 1993-12-09 | The United States Government As Represented By The Secretary Of The Department Of Health And Human Services | Improved expression of human multidrug resistance genes and improved selection of cells transduced with such genes |
| US5830697A (en) * | 1997-01-21 | 1998-11-03 | The Board Of Trustees Of The Leland Stanford Junior University | P-glycoprotein mutant resistant to cyclosporin modulation |
-
2000
- 2000-09-28 AT AT00967072T patent/ATE346924T1/de not_active IP Right Cessation
- 2000-09-28 DE DE60032161T patent/DE60032161D1/de not_active Expired - Lifetime
- 2000-09-28 EP EP00967072A patent/EP1220911B1/en not_active Expired - Lifetime
- 2000-09-28 AU AU77327/00A patent/AU785363B2/en not_active Ceased
- 2000-09-28 WO PCT/US2000/026767 patent/WO2001023540A2/en not_active Ceased
- 2000-09-28 JP JP2001526923A patent/JP2003510071A/ja active Pending
- 2000-09-28 CA CA002384981A patent/CA2384981A1/en not_active Abandoned
-
2011
- 2011-12-26 JP JP2011284080A patent/JP2012061008A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| AU785363B2 (en) | 2007-02-01 |
| EP1220911A2 (en) | 2002-07-10 |
| ATE346924T1 (de) | 2006-12-15 |
| AU7732700A (en) | 2001-04-30 |
| JP2012061008A (ja) | 2012-03-29 |
| WO2001023540A3 (en) | 2001-10-18 |
| JP2003510071A (ja) | 2003-03-18 |
| EP1220911B1 (en) | 2006-11-29 |
| WO2001023540A2 (en) | 2001-04-05 |
| CA2384981A1 (en) | 2001-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0116452A (pt) | Composto, composição farmacêutica, uso de um composto | |
| CY1106708T1 (el) | Πυρηνικα οξεα και πολυπεπτιδια υποδοχεα | |
| ATE377597T1 (de) | Anilinochinazoline als protein-tyrosin- kinasehemmer | |
| PT966465E (pt) | Inibidores do enzima imfdh | |
| DE60021282D1 (de) | Carbamat-derivate als muscarin-rezeptor antonisten | |
| ATE469151T1 (de) | Pyrrolopyridinderivate als proteinkinaseinhibitoren | |
| WO2002089738A3 (en) | Proteomimetic compounds and methods | |
| EA200700142A1 (ru) | Замещенные гетероциклом циклические производные мочевины, их получение и их фармацевтическое применение в качестве ингибиторов киназы | |
| ATE300533T1 (de) | 1,2,3,4-tetrahydroisochinolin-derivate als urotensin ii rezeptor-antagonisten | |
| NO20001598D0 (no) | Apolipoprotein A-1-agonister og deres anvendelse for Õ behandle dyslipidemiske forstyrrelser | |
| ATE312090T1 (de) | 4-(piperidyl- und pyrrolidyl-alkyl-ureido)- chinoline als urotensin ii rezeptor antagonisten | |
| BR0314797A (pt) | Derivados da pirimidineamida e o uso dos mesmos | |
| SE0202598D0 (sv) | Alpha-7 Nicotinic receptor agonists and statins in combination | |
| ATE549353T1 (de) | Aktive varianten des il-18 bindenden proteins und dessen medizinische verwendungen | |
| DK1234025T3 (da) | Humane enzymer fra metalloproteasefamilien | |
| ATE266722T1 (de) | Zyklische peptidomimetische urokinaserezeptorantagonisten | |
| DE60032161D1 (de) | P-glycoproteine und ihre verwendungen | |
| ATE247130T1 (de) | Inhibitoren für den urokinaserezeptor | |
| EP1293567A4 (en) | GPR8 LIGAND AND DAFUER ENCODING DNA (02.01.02) | |
| CY1111004T1 (el) | Χρησιμες συνθεσεις για τη ρυθμιση της δρασης του γονιδιου της παρκινης | |
| WO2002074048A3 (en) | P-glycoproteins and uses thereof | |
| ATE420162T1 (de) | Verfahren und zusammensetzungen zum targeting sekretorischer lysosomen | |
| ATE397663T1 (de) | Humane ltrpc7 proteine, dafür kodierende nukleinsäuren und deren verwendungen | |
| MXPA05006587A (es) | Compuestos de tiazol como derivados de antagonistas del receptor de la integrina. | |
| ITFI20030238A1 (it) | Peptidi ciclici antagonisti dell'urotensina-ii |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8332 | No legal effect for de |